Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in ...

The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a ... head of connected care for Lilly Diabetes. "Using the learnings from early adopters of Tempo, we look ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Lilly is developing Tempo Smart ... "Our smart connected insulin pens aim to empower people to better understand their diabetes management, have more informed conversations with their doctor ...

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Eli Lilly is counting on Camurus and its long-acting delivery technology to help take its portfolio of obesity and diabetes drugs to the next level with a licensing deal worth up to $870 million.

Camurus and Lilly have entered a collaboration and license agreement, granting Lilly exclusive, worldwide rights to the ...

Medicare will cover a portion of the cost of your insulin pump if you have a doctor’s prescription and meet the following criteria: You complete a comprehensive diabetes education program ...

The global insulin delivery pen market is estimated to record a CAGR of 8.1% from 2024 to 2034. This is likely to take the ...